IL17A and alcoholic fatty liver disease: The association of inflammation in MAFLD has been recently confirmed as IL‐17, a pro‐inflammatory cytokine was shown to be involved in the development of alcoholic fatty liver disease, viral hepatitis, cholestatic cirrhosis, and other chronic liver diseases (Lafdil et al., 2010; Tan et al., 2013).